Cite
HARVARD Citation
Wu, S. et al. (2015). Clinicopathological characteristics and outcomes of ROS1‐rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements. Thoracic cancer. 6 (4), pp. 413-420. [Online].